Global Rivastigmine Market Is Estimated To Witness High Growth Owing To Increasing Geriatric Population And Rising Prevalence Of Alzheimer's Disease
Market Overview:Rivastigmine is a medication used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. It belongs to the cholinesterase inhibitors class of drugs and is available in the form of oral capsules, oral solutions, and transdermal patches. The market for Rivastigmine is driven by the increasing geriatric population worldwide and the rising prevalence of...
0 Comments 0 Shares 1678 Views 0 Reviews
Sponsored